Obesity is a chronic health condition, and findings from a recent clinical trial 3 suggest that ongoing support is essential for sustaining progress in weight and overall health, said Satya Jonnalagadda, Vice President of Scientific and Clinical Affairs at Medifast
We observed elevated MG levels in both clinical and experimental models of kidney injury and linked their accumulation to a metabolic shift towards glycolysis and renal impairment
Surgical Interventions Several surgical interventions are approved in the treatment of obesity including devices (e.g., intragastric balloon, endoscopic sleeve gastroplasty, vagal nerve blockade, hydrogels) and surgery [e.g., laparoscopic adjustable gastric banding (LAGB), roux-en-Y gastric bypass (RYGB), biliopancreatic diversion with duodenal switch (BPD-DS)]
Together, these findings strongly support the pro-nociceptive role of acrolein likely via TRPA1 activation, as deduced by increased levels of this receptor in sensory ganglia also observed in the referred study